Search

Your search keyword '"Azzaoui, I."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Azzaoui, I." Remove constraint Author: "Azzaoui, I."
42 results on '"Azzaoui, I."'

Search Results

4. Le déficit en interféron de type I n’altère pas la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après vaccination par ARNm

5. La vaccination par ARNm des sujets naïfs ou convalescents de la COVID-19 permet la génération de lymphocytes B mémoires capables de reconnaître et de neutraliser les variants du SARS-CoV-2

6. Maturation et persistance de la réponse lymphocytaire B mémoire anti-SARS-CoV-2

8. Des lymphocytes B mémoires avec un phénotype unique persistent dans la rate de patients traités par rituximab au cours de la thrombopénie immunologique de l’adulte

9. Un réservoir de lymphocytes B mémoires ayant résisté au rituximab participe aux rechutes à distance du traitement au cours de la thrombopénie immunologique de l’adulte

10. Efficacité et tolérance du traitement combinant rituximab et belimumab au cours de la thrombopénie immunologique persistante et chronique de l’adulte : résultats d’un essai de phase IIb

12. CORRELATION BETWEEN PRE-TREATMENT LEVEL OF SOLUBLE PD-L1 AND OUTCOME IN CLASSICAL HODGKIN LYMPHOMA INCLUDED IN A PROSPECTIVE STUDY OF THE LYMPHOMA STUDY ASSOCIATION

13. French Intensive Care Society, International congress - Réanimation 2016

18. French Intensive Care Society, International congress – Réanimation 2016

19. Intraperitoneal chronic expanding hematoma mimicking an ovarian tumor: A case report.

20. SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.

21. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

22. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.

23. Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2- Recovered Dialysis Patients.

24. High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura.

25. Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.

26. Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.

27. mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.

28. Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

29. Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.

30. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.

31. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.

32. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.

34. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.

35. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.

36. Polycyclic aromatic hydrocarbons reciprocally regulate IL-22 and IL-17 cytokines in peripheral blood mononuclear cells from both healthy and asthmatic subjects.

37. Acute alcohol exposure has an independent impact on C-reactive protein levels, neutrophil CD64 expression, and subsets of circulating white blood cells differentiated by flow cytometry in nontrauma patients.

39. CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma.

40. Pulmonary CCL18 recruits human regulatory T cells.

41. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects.

42. The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects.

Catalog

Books, media, physical & digital resources